Immediate Impact
63 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of Harry Harper being referenced
Genomic Profiling of Advanced Non–Small Cell Lung Cancer in Community Settings: Gaps and Opportunities
2017
Prognostic factors for brain metastasis in non-small cell lung cancer (NSCLC): A single Institution’s experience for over 10 years.
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Harry Harper | 206 | 102 | 44 | 119 | 11 | 287 | |
| Elaine Wiegert | 128 | 74 | 62 | 58 | 9 | 306 | |
| Ana B. Galván | 135 | 108 | 79 | 71 | 13 | 300 | |
| Damien Mikael Hansra | 89 | 204 | 30 | 66 | 16 | 264 | |
| Franz J. Hilke | 67 | 111 | 57 | 87 | 15 | 266 | |
| Nicole Caixeiro | 82 | 156 | 94 | 145 | 14 | 309 | |
| Maria Grazia Mameli | 134 | 113 | 118 | 48 | 11 | 299 | |
| Ekkehard Grundmann | 80 | 107 | 63 | 144 | 12 | 300 | |
| Lars Buschhorn | 73 | 94 | 98 | 104 | 11 | 243 | |
| Priyanka Gopal | 123 | 90 | 114 | 77 | 14 | 300 | |
| Paz J. Vellanki | 106 | 151 | 53 | 48 | 12 | 227 |
All Works
Loading papers...